Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML
Clinical trial NCT04842370 · UNKNOWN
Trial details
- NCT number
- NCT04842370
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-08
- Primary completion
- 2022-05-21
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.